8ZD-28740-85014
4 vaccinations
3 coded responses
41 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 208 / MD
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: Very minor headache (went away quickly, no pain med even needed.) Debated even reporting it since it was so mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
-
2021-04-28
Survey response — day 21, single doseMedDRA: Chest pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Chest pain - had to be admitted to hospital and they found multiple PEs (pulmonary embolisms.) I am now back home on blood thinners and feeling better, but need to follow up with a hemotologist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Report sent to call center — day 21, single doseBe unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-05
- 2021-05-12
-
2021-05-19
Survey response — day 42, single doseMedDRA: Paraesthesia — Feeling: GoodFree text: For a couple of weeks now, I feel tingling and/or missing circulation in both feet and ankles. It comes and goes, so Im not sure whats causing it. Doesnt seem to be circulation-related as compression socks nor raising legs/feet seemMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
-
2021-05-26
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-07
- 2021-10-06
-
2021-11-16
Dose 2 — Pfizer-BioNTech
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-02-15
-
2022-04-08
Dose 3 — Pfizer-BioNTech
- 2022-05-03
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-08
-
2022-09-24
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-11
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-12-24
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-16 | Pfizer-BioNTech | No |
| 3 | 2022-04-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-24 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Very minor headache (went away quickly, no pain med even needed.) Debated even reporting it since it was so mild.
Release 8 — day 21, single dose
Symptoms: Chest pain - had to be admitted to hospital and they found multiple PEs (pulmonary embolisms.) I am now back home on blood thinners and feeling better, but need to follow up with a hemotologist.
Release 8 — day 42, single dose
Symptoms: For a couple of weeks now, I feel tingling and/or missing circulation in both feet and ankles. It comes and goes, so Im not sure whats causing it. Doesnt seem to be circulation-related as compression socks nor raising legs/feet seem
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release